Navigation Links
Reportlinker Adds Strategic Analysis of End-user Preferences in the U.S. Stem Cell Research Tools Markets
Date:8/19/2010

NEW YORK, Aug. 19 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Strategic Analysis of End-user Preferences in the U.S. Stem Cell Research Tools Markets

http://www.reportlinker.com/p0258289/Strategic-Analysis-of-End-user-Preferences-in-the-US-Stem-Cell-Research-Tools-Markets.html

The primary objective of this study is to measure brand perceptions of tools and technologies currently at the forefront of stem cell research. Stem cell researchers' preferences are assessed for five categories of technologies: bio-imaging and microscopy, cell biology tools, immunochemicals, molecular biology tools, and protein biochemistry tools. Additionally, the study measures researchers' current and future plans for stem cell research as well as their perceptions of equipment manufacturers. One hundred and fifty seven customers of tools and equipment for stem cell research participated in an extensive on-line survey. 

1 TECHNOLOGY PREFERENCES AMONG STEM CELL RESEARCHERS

Introduction

1. Title

2. Disclaimer

3. Certification

4. Table of Contents

Purpose of Research and Profile of Respondents

1. Purpose of Research

Executive Summary

1. Executive Summary

Total Stem Cell Research Tools Market

1. General and Primary Focus of Stem Cell Research

2. Tools and Equipment Budget for Stem Cell Research

3. Anticipated High-Impact Emerging Technologies

Bio-Imaging and Microscopy Tools Market for Stem Cell Research

1. Technologies Employed for Stem C
'/>"/>

SOURCE Reportlinker
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Reportlinker Adds Production and Market of Xylose in China
2. Reportlinker Adds Advances in Large Scale BioManufacturing and Scale-Up Production, 2nd ED
3. Reportlinker Adds European Markets for Small Joint Reconstructive Devices 2010 (15 Countries)
4. Reportlinker Adds Japanese Market for Small Joint Reconstructive Devices 2010
5. Reportlinker Adds Effective Social Media Marketing Strategies for Pharmaceutical Market
6. Reportlinker Adds Wireless Medical Technologies 2007-2010
7. Reportlinker Adds European Market for Ventilation and Airway Management Devices
8. Reportlinker Adds Western European Disinfectant Gels and Scrubs Market
9. Reportlinker Adds Global Pharma-biotech Alliance Analysis
10. Reportlinker Adds 2010 U.S. Ophthalmologists Assessment of Eye Care Medication Brands
11. Reportlinker Adds European Markets for Gastrointestinal Endoscopic Devices 2010 (15 Countries)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/22/2014)... 2014 Many power shifts are occurring ... of patients in the biopharmaceutical market is impacting ... than ever, understanding how to effectively acquire, convert, ... essential. According to recent research ... spent about two-thirds of their patient-focused dollars on ...
(Date:11/21/2014)... Nov. 21, 2014 In September 2014, the ... carried out a new product development plan that started ... "limited edition" lab coat , aptly named "Vera ... surgery in the world. The new women,s designer lab ... with a sleek envelope collar, vertical princess and high ...
(Date:11/21/2014)... , Nov. 21, 2014  PTC Therapeutics, Inc. (NASDAQ: ... 2014 Legend of Technology Award for Vision, Innovation, and Leadership ... Chief Executive Officer. This award recognizes an individual who has ... New Jersey for several decades. ... Award," stated Stuart Peltz , Ph.D., CEO of PTC ...
Breaking Medicine Technology:New Report Details Importance of Adopting a "Patient Journey" Framework in Marketing 2Medelita Introduces Medical Industry's First Limited Edition Women's Designer Lab Coat 2PTC Therapeutics Announces CEO, Dr. Stuart Peltz Recipient of The New Jersey Technology Council's 2014 Legend of Technology Award 2PTC Therapeutics Announces CEO, Dr. Stuart Peltz Recipient of The New Jersey Technology Council's 2014 Legend of Technology Award 3
... HARRISBURG, Pa., Dec. 20, 2011  As part of a national ... care facilities with flu vaccination rates for staff of 90 ... www.flufreepa.com . "Increasing vaccination among health care ... and ensure the health of all Pennsylvanians," said Secretary of ...
... 20, 2011 /PRNewswire-Asia-FirstCall/ -- Mindray Medical International Limited (NYSE: ... marketer of medical devices worldwide, announced today an agreement ... Biotech Co., Ltd. ("TDR"). The terms of the agreement ... Mindray,s financial statements. Founded in 1997 and ...
Cached Medicine Technology:Pennsylvania Department of Health Lauds Health Care Facilities for Boosting Flu Vaccination Rates among Workforce 2Mindray Medical to Acquire a Controlling Stake in Hunan Changsha TDR Biotech 2Mindray Medical to Acquire a Controlling Stake in Hunan Changsha TDR Biotech 3
(Date:11/22/2014)... 22, 2014 Setria® Glutathione is ... approved it for use “as a therapeutically active ... within the Therapeutic Goods (Listing) Notice 2014 (No. ... Hakko’s Setria® Glutathione will be exclusivity distributed in ... sources and imports fine chemicals to Australian manufacturers. ...
(Date:11/22/2014)... PITTSBURGH, PA (PRWEB) November 22, 2014 ... about the pain caused by the machine," said an ... injury, she had to go back a second time ... my invention idea." , She developed the patent-pending MAMO ... for breast cancer. The design saves the patient from ...
(Date:11/22/2014)... Lipitor lawsuits ( http://www.lipitorlawsuitcenter.com/ ) that ... developed Type 2 diabetes due to its use continue ... underway in U.S. District Court, District of South Carolina, ... litigation will convene its next Status Conference on December ... Counsel for Plaintiffs and Defendants to meet and confer, ...
(Date:11/22/2014)... November 22, 2014 The Sports Conflict ... Roy Baroff to its team of conflict resolution professionals. ... player, coach, and referee. He has over 30 years experience ... beyond. , “I'm very excited to connect with SCI and ... related interests to a program with a complete sports focus,” ...
(Date:11/22/2014)... (PRWEB) November 22, 2014 Wright & ... AndroGel side-effects lawsuits have been scheduled between October ... Northern District of Illinois. U.S. District Judge Matthew F. ... a Case Management Order (CMO) on November 6, 2014 ... for attorneys to submit documents and other activities in ...
Breaking Medicine News(10 mins):Health News:Setria® Glutathione Now Available in Australia 2Health News:Setria® Glutathione Now Available in Australia 3Health News:Lipitor Lawsuit Conference Scheduled for December, Bernstein Liebhard LLP Reports 2Health News:Lipitor Lawsuit Conference Scheduled for December, Bernstein Liebhard LLP Reports 3Health News:SCI Announces New Team Member Roy Baroff 2Health News:SCI Announces New Team Member Roy Baroff 3Health News:First Bellwether Trials Scheduled In AndroGel Side-Effects Lawsuits Reports Wright & Schulte LLC 2Health News:First Bellwether Trials Scheduled In AndroGel Side-Effects Lawsuits Reports Wright & Schulte LLC 3Health News:First Bellwether Trials Scheduled In AndroGel Side-Effects Lawsuits Reports Wright & Schulte LLC 4
... The addition of zoledronic acid to adjuvant endocrine therapy ... disease recurrence among postmenopausal women with early hormone receptor-positive ... trial. Richard de Boer, M.D., of the ... from the Zometa-Femara Adjuvant Synergy Trial (ZO-FAST) trial at ...
... Treating ,brain tsunamis, or ,killer waves, could stop many victims ... study published in Lancet Neurology has found. ... the topic of spreading depolarizations now of keen interest to ... signature wound of the wars in Iraq and Afghanistan. ...
... - A majority of Americans professing belief in God ... the spread of nuclear weapons - branding it a ... conducted jointly by the University of Maryland,s Center for ... Program on International Policy Attitudes (PIPA). The nearly ...
... off a "genomic storm" in human immune cells, altering ... patterns. In a report to appear in the ... a nationwide research collaborative describe the initial results of ... injury, findings which have overturned some longstanding assumptions. ...
... with hormone receptor-positive metastatic breast cancer may have a ... to results of a study by the SWOG clinical ... San Antonio Breast Cancer Symposium. The combination of ... the SWOG S0226 trial extended the median survival time ...
... recognize the following scenario: Their favorite player scores a three-point ... ball. But does the fact that he scored the last ... it change the probability that he will score again? ... Neiman at the Hebrew University in Jerusalem shatters the myth ...
Cached Medicine News:Health News:Immediate bisphosphonate use with endocrine therapy reduced recurrence and increased survival in postmenopausal early breast cancer 2Health News:Brain tsunamis' are clue to helping victims of major head injuries 2Health News:Brain tsunamis' are clue to helping victims of major head injuries 3Health News:US believers favor international action on climate change, nuclear risk: UMD poll 2Health News:US believers favor international action on climate change, nuclear risk: UMD poll 3Health News:Traumatic injury sets off a 'genomic storm' in immune system pathways 2Health News:Traumatic injury sets off a 'genomic storm' in immune system pathways 3Health News:Anti-estrogen combo better than single drug for hormone-sensitive breast cancer 2Health News:Heads up Kobe Bryant! Research shows that trying for another 3-pointer is a mistake 2
Pain management can be complicated. But that doesn't mean your PCA infusion system should be. The new SYNDEO PCA Syringe Pump streamlines pain therapy with a powerful combination of intelligent desig...
... The COLLEAGUE pumps can be customized ... range of care sites and therapies. The ... delivery sets to be used for both ... and excess costs. From simple infusions to ...
... Established in 1979, CRL ... services in the areas ... Insurance, Clinical Trials and ... one roof at our ...
Millenova Immunology Laboratories is a reference laboratory dedicated to the diagnosis of immunologic causes of reproductive failure, infertility and recurrent pregnancy loss....
Medicine Products: